Medications for schizophrenia

Photo of patient and doctor talking

Antipsychotic medications (neuroleptics) reduce the symptoms of psychosis and prevent further episodes. But they can have some unpleasant side effects. The decision whether or not to use them will depend on the person's situation and the phase of the disease.

Antipsychotics block the activity of certain nerve cells in the brain. This has a calming effect and reduces hallucinations and delusional thoughts. Often called neuroleptics in the past, antipsychotics belong to a group of medications called . Although they can’t “cure” schizophrenia, they are sometimes the only treatment that can relieve the symptoms and prevent future acute psychotic episodes (relapses). This can help people to get by better in daily life and be more socially active again. People whose schizophrenia is well managed also tend to live longer.

Sleeping pills and anti-anxiety drugs () can help for a while in people who are very restless and are having problems sleeping. These medications are usually taken in addition to antipsychotics. Antidepressants can be used to treat symptoms of .

Some people take antipsychotic tablets or drops for a short while only, and others take them for many years or even for the rest of their life. Alternatively, the medication can be given in the form of a depot (slow-release) injection, which works over a longer period of time. These injections contain the same drug, which is injected into a muscle at regular intervals (every few weeks or months). The advantage of depot injections is that you don't have to remember to take the medication every day.

How well do antipsychotics work in acute psychosis?

Antipsychotics mainly reduce abnormal perceptions such as delusions and hearing voices, and they help you to feel calmer too. They have less of an effect on – but can also improve – symptoms such as depression, lack of drive, and concentration and memory problems.

Various studies have shown that the symptoms improve within six weeks in

  • about 30 out of 100 people who take a placebo (fake drug) and
  • about 50 out of 100 people who take antipsychotics.

Some people also said that their quality of life had improved and they were able to return to their normal daily life sooner.

It often takes a while for the medication to start working: In many cases it already has a noticeable effect within a few hours or days, but it can sometimes take several weeks instead. If the symptoms don’t improve within two to four weeks despite taking a higher dose, it’s unlikely that the medication will start working after that. Then a different medication should be tried out.

The effectiveness of antipsychotics depends on a number of factors and varies from person to person. The following may play a role:

  • Whether it's the person’s first episode of acute psychosis, or whether they have already had episodes in the past
  • The type and severity of the symptoms
  • The exact drug and dose used

How well can antipsychotics prevent further episodes (relapses)?

Several studies have shown that relapses occurred within one year in

  • about 61 out of 100 people who took a placebo (fake drug) and
  • about 23 out of 100 people who took antipsychotics.

People who took antipsychotics also didn't have to go to the hospital for treatment as often.

How long someone uses the medication for will depend on things like how many acute psychotic episodes they have already had and how severe the episodes were. Treatment with antipsychotics shouldn't be stopped suddenly because that can increase the risk of a relapse. So it’s important to talk to the doctor about the best way to come off the medication.

What are the side effects of antipsychotics?

The possible side effects of antipsychotics are:

  • Abnormal movements (shakiness, muscle stiffness, decreased movement)
  • Involuntary movements like smacking your lips, making faces and moving your head
  • Trouble swallowing
  • Metabolic problems
  • Restlessness
  • Weight gain
  • Higher risk of diabetes
  • Dry mouth
  • Difficulty peeing
  • Vision problems (for example, blurred vision)
  • Dizziness and headaches
  • Tiredness and lack of drive

In rare cases, people may have an irregular heartbeat or serious blood-cell-production problems. Regular blood tests are done for this reason. The risk of pneumonia can also increase somewhat.

Some types of abnormal movement only develop after the medication has been taken for a long time, sometimes even years. In that case, it often lasts for a long time and is difficult to treat.

Which side effects you have (if any) depends on the active ingredient in the medication and the dosage.

There is not enough research on the effects of taking antipsychotic medications for a long time. It is thought that taking them for many years may lead to changes in some areas of the brain. But it's not clear whether this actually happens and, if so, what effects it has.

How do the various antipsychotic medications differ?

Antipsychotic medications have traditionally been divided into the following types:

  • First-generation antipsychotics (typical antipsychotics)
  • Second-generation antipsychotics (atypical antipsychotics)

This classification is no longer entirely correct. Put simply, though: The medications in the different groups affect different receptors in the brain, but they reduce the symptoms of schizophrenia to a similar extent. The key differences:

  • First-generation antipsychotics are more likely to cause abnormal motor behavior (abnormal movements).
  • Second-generation antipsychotics are more likely to cause weight gain and metabolic problems.
  • Some second-generation antipsychotics are a little better at reducing lack of drive and concentration problems.

Sometimes the differences depend more on the specific active ingredient in the medication rather than the group it belongs to. It is not completely clear how important these differences are, and it's still a matter of debate.

What’s the difference between high-potency and low-potency antipsychotics?

First-generation antipsychotics are further divided into two groups described as high-potency and low-potency. Both groups are similarly effective, but they differ in the dosages used and their potential side effects:

  • Lower doses of high-potency antipsychotics have the same effect as higher doses of low-potency antipsychotics. But high-potency antipsychotics are more likely to cause abnormal motor behavior (muscle stiffness, trembling, fidgeting) and involuntary movements (chewing, lip-smacking, head movements).
  • Low-potency antipsychotics tend to make you tired and have a calming effect. They are also more likely to cause problems affecting the vegetative nervous system, with a dry mouth and digestive problems.

How is the medication chosen?

There are no general rules to say which medication is most suitable in a particular situation. Different doctors might recommend different medications. One reason for this is because most studies haven't found any major differences between the individual medications in terms of their effectiveness.

It is always important to check how somebody responds to a medication, anyway. The goal is to find the most effective dose with the fewest side effects. If a medication doesn't help enough, it’s possible to increase the dose or switch to a medication with a different active ingredient.

Most people start on a low dose and then gradually increase it. Sometimes a high dose is used from the start to quickly reduce the symptoms of acute psychosis.

It is often enough to use just one antipsychotic medication. Experts generally do not recommend combining two or more antipsychotic medications, even if this is often done in practice. Research has shown that combining medications only helps a small number of patients who have very severe symptoms, if it helps at all – especially because the risk of interactions between medications increases with each additional medication. More research is needed on the pros and cons of the different combinations.

Do antipsychotics always help in schizophrenia?

Antipsychotic medications can reduce the symptoms and consequences of schizophrenia. But their side effects can be unpleasant, and not everyone needs to take them. So it’s important to carefully weigh their pros and cons before making a decision. The following factors play a role:

  • What is the goal of treatment?
  • How bad are the symptoms?
  • What phase of the disease is to be treated?
  • What are the potential consequences of having another episode of acute psychosis?
  • What would switching medications do?
  • What would happen without medication?
  • How serious are the side effects?
  • Can the dose be adjusted to make the side effects tolerable?
  • How effective were previous treatments?
  • What are the other treatment and support options?

Even if medications reduce acute psychotic symptoms and prevent relapses, that might not always be the main treatment goal. It is also important to consider how much the person and their loved ones are suffering from – or at risk due to – the symptoms and their consequences.

In acute psychosis, doctors usually agree that treatment with antipsychotic medications is necessary. But if the symptoms are mild, medications might not be needed, or very low doses might be used. This may also be the case if the effects of a psychotic episode are limited and the person has good support from others during this time. The same is true if a relapse is unlikely – although it’s impossible to know for sure if a relapse is unlikely to occur.

It is important that people with schizophrenia are involved in the planning of their treatment and that their wishes are respected. But that’s often not the case, and it can be difficult to do in an acute phase. It may be easier once the acute symptoms have improved. After some time has passed, you can discuss whether the treatment with medication can be stopped at some point or whether it might be better to continue taking the medication over the long term.

In order to make an informed decision together with doctors, you have to be fully informed about the effects that the medication can have. This information also helps when defining personal treatment goals.

Ceraso A, Lin JJ, Schneider-Thoma J et al. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2020; (8): CD008016.

Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). S3-Leitlinie Schizophrenie (Living Guideline). AWMF register no.: 038-009. 2025.

Fountoulakis KN, Stahl SM. The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms. J Psychopharmacol 2022; 36(4): 428-438.

Galling B, Roldan A, Hagi K et al. Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis. World Psychiatry 2017; 16(1): 77-89.

Huhn M, Nikolakopoulou A, Schneider-Thoma J et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 2019; 394(10202): 939-951.

Huhtaniska S, Jääskeläinen E, Hirvonen N et al. Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis. Hum Psychopharmacol 2017; 32(2).

Jia N, Li Z, Li X et al. Long-term effects of antipsychotics on mortality in patients with schizophrenia: a systematic review and meta-analysis. Rev Bras Psiquiatr 2022; 44(6): 664–673.

Leucht S, Leucht C, Huhn M et al. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. Am J Psychiatry 2017; 174(10): 927-942.

Leucht S, Vauth R, Olbrich HM et al. Schizophrenien und andere psychotische Störungen. In: Psychische Erkrankungen - Klinik und Therapie. Munich: Urban und Fischer; 2015.

Lochmann van Bennekom MW, IntHout J, Gijsman HJ et al. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data. Schizophr Res 2024; 272: 1-11.

McDonagh MS, Dana T, Selph S et al. Treatments for Schizophrenia in Adults: A Systematic Review (AHQR Comparative Effectiveness Reviews; No. 198). 2017.

Ortiz-Orendain J, Castiello-de Obeso S, Colunga-Lozano LE et al. Antipsychotic combinations for schizophrenia. Cochrane Database Syst Rev 2017; (6): CD009005.

Ostuzzi G, Vita G, Bertolini F et al. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis. Lancet Psychiatry 2022; 9(8): 614-624.

Rubio JM, Schoretsanitis G, John M et al. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis. Lancet Psychiatry 2020; 7(9): 749-761.

Schneider-Thoma J, Chalkou K, Dorries C et al. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis. Lancet 2022; 399(10327): 824-836.

IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.

Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.

Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.

Comment on this page

What would you like to share with us?

We welcome any feedback and ideas - either via our form or by gi-kontakt@iqwig.de. We will review, but not publish, your ratings and comments. Your information will of course be treated confidentially. Fields marked with an asterisk (*) are required fields.

Please note that we do not provide individual advice on matters of health. You can read about where to find help and support in Germany in our information “How can I find self-help groups and information centers?

Über diese Seite

Updated on May 26, 2026

Next planned update: 2029

Publisher:

Institute for Quality and Efficiency in Health Care (IQWiG, Germany)

Stay informed

Subscribe to our newsletter or newsfeed. You can find our growing collection of films on YouTube.